Molecular Imaging of Immunotherapy Targets in Cancer. - Wikidata - awgldk - TriplyDB

Molecular Imaging of Immunotherapy Targets in Cancer.

Molecular Imaging of Immunotherapy Targets in Cancer.

http://www.wikidata.org/entity/Q37309882

about

(89)Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer.ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.The new era of cancer immunotherapy: what can molecular imaging do to help?Current status and future challenges for molecular imaging.Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody.PET and SPECT imaging of melanoma: the state of the art.Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Imaging PD-L1 Expression with ImmunoPET.CD38 as a PET Imaging Target in Lung Cancer.ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab.A Switchable Site-Specific Antibody Conjugate.In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET

P2860

Q38617885-7139AE7C-9277-419C-AC80-7AF673A6DDD6 Q38733611-7ACCE611-078C-4D5A-B976-C6147F01D274 Q38795442-1A79AB20-0FD1-4DA6-801D-5168CDFC85C4 Q39069273-CD06CF37-6728-423B-BF45-174FDF6D6120 Q47308572-C967C6C4-021C-4137-87AA-BB31A18FEEE4 Q47646469-13D38213-1005-4EDD-A80E-A12626200B1E Q47777542-6BAF1638-383A-4CFB-A61C-A3277AA3FE1E Q47868574-F648D30D-360A-4768-A7BB-C3187E0CCAFA Q48227716-5E8DA152-6400-4CDB-BC77-371E73CA95C2 Q48324917-9BA10CE3-2A45-49D8-A1D2-92EB67625D6D Q48337576-9A73C754-534D-48AF-B4E8-6F687F4C493A Q49950717-B1BEA813-E967-4F23-8248-C09559BE686D Q50027030-55F8F805-161D-4A65-9A63-6D841DA23E72 Q58778667-EB272BE4-1EBE-40C0-B38D-54ECBEACBB66

P2860

Molecular Imaging of Immunotherapy Targets in Cancer.

http://www.wikidata.org/entity/Q37309882

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular Imaging of Immunotherapy Targets in Cancer.

@en

Molecular Imaging of Immunotherapy Targets in Cancer.

@nl

type

label

Molecular Imaging of Immunotherapy Targets in Cancer.

@en

Molecular Imaging of Immunotherapy Targets in Cancer.

@nl

prefLabel

Molecular Imaging of Immunotherapy Targets in Cancer.

@en

Molecular Imaging of Immunotherapy Targets in Cancer.

@nl

P1433

Q37309882-D91D5C87-C5E4-4FCC-82C5-68D7B142B9F1

P1476

Q37309882-8EFFE84F-55DF-40AF-8036-77B49535AFFB

P2093

Q37309882-1D48C692-E1D9-4988-96DD-BAEE7C386305

Q37309882-B4EBC5CC-DA87-4AF0-A162-B47274AB9253

Q37309882-C822DF88-592F-43DA-9071-CF86B94A836B

Q37309882-F87E566B-D339-4795-87DB-2005C6B0B4EE

P2860

Q37309882-0293F9C9-47C0-4432-841B-B231CD02DE0C

Q37309882-0C3FBB41-14CA-4D33-9B8A-951529E4D558

Q37309882-16AB21D7-0F9E-4D73-B4F5-F8D02BC45760

Q37309882-1C2C29AE-7F27-4FF0-9A69-6364B0357992

Q37309882-3000E31A-AC17-467E-87BD-A4168307CC7A

Q37309882-3185E8FD-B474-4132-BA1B-AA8546451416

Q37309882-42A9C65B-E5BF-4A0C-A0DF-554B7D643A30

Q37309882-441C8E27-B9E5-4524-8FDB-27E5282FBF8C

Q37309882-4D1837FE-FC1D-4334-A454-774C79904386

Q37309882-591F23F7-D38C-4EB6-A904-9030EEB2CA20

P304

Q37309882-CCCD0D4F-140B-4495-B7FD-5E9FF78F0996

P31

Q37309882-35061894-BF14-4450-9063-76DD2977A477

P356

Q37309882-51CCAD12-B061-4F21-8DAB-6CC10A2E96C7

P407

Q37309882-B77174A4-AE02-46D4-9852-070BCD526CDC

P433

Q37309882-9B8B8174-E186-4D3C-98C3-2F5804C42829

P478

Q37309882-E5619172-6F1C-4D26-8989-CE5E5E95670E

P577

Q37309882-D67F5C49-4753-4F58-9F04-4A6C2C1BD681

P698

Q37309882-E6769A28-ABCE-4F4D-A1F5-75707F1AE750

P921

Q37309882-2378E48D-ADB9-4603-8737-73C1FC1E6E1F

P932

Q37309882-B9D1CA62-F585-4420-BCBC-CAC53D461016

P356

JNUMED.116.177493

P1433

The Journal of Nuclear Medicine

P1476

Molecular Imaging of Immunotherapy Targets in Cancer.

@en

P2093

Christopher G England

http://www.w3.org/2001/XMLSchema#string

Douglas G McNeel

http://www.w3.org/2001/XMLSchema#string

Emily B Ehlerding

http://www.w3.org/2001/XMLSchema#string

Weibo Cai

http://www.w3.org/2001/XMLSchema#string

P2860

CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

The blockade of immune checkpoints in cancer immunotherapy

Immune checkpoint blockade: a common denominator approach to cancer therapy

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

Pembrolizumab for the treatment of non-small-cell lung cancer

64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues

Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging

P304

1487-1492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.116.177493

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27469363

http://www.w3.org/2001/XMLSchema#string

P921

P932

5050107

http://www.w3.org/2001/XMLSchema#string